Sermonix Pharmaceuticals
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $40M
Investors
- 1
About Sermonix Pharmaceuticals
Sermonix Pharmaceuticals Inc.Founded in 2014 in Columbus, US, Sermonix Pharmaceuticals Inc. is dedicated to advancing female-specific oncology products.Sermonix Pharmaceuticals specializes in developing and commercializing female-specific oncology products, primarily focusing on lasofoxifene, a selective estrogen receptor modulator (SERM) aimed at treating breast cancer. Lasofoxifene is currently under investigation for its effectiveness in postmenopausal and premenopausal women with locally advanced or metastatic estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer with an ESR1 mutation.Sermonix Pharmaceuticals generates revenue by commercializing its oncology products and forming partnerships with healthcare providers and research institutions for clinical trials and distribution. The company employs a B2B model, collaborating with hospitals, oncology clinics, and healthcare networks to deliver therapies directly to healthcare professionals. The pricing for lasofoxifene and related services is influenced by market conditions and therapeutic benefits, allowing healthcare providers to offer advanced treatment options.Sermonix Pharmaceuticals Inc. The company aims to expand into new markets, specifically targeting regions with high breast cancer incidence, and is focused on enhancing its product offerings to meet the needs of healthcare providers. Future initiatives will build on the current partnerships to facilitate access to innovative treatment options.
Who invested in Sermonix Pharmaceuticals
1 investor across 1 round
See all investors in Sermonix Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 12, 2021
Amount
$40M
Investors
Questions about Sermonix Pharmaceuticals
Who invested in Sermonix Pharmaceuticals?
Sermonix Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sermonix Pharmaceuticals raised?
Sermonix Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sermonix Pharmaceuticals last raise money?
Sermonix Pharmaceuticals's most recent round on record is a Series A, in Nov 2021.
What does Sermonix Pharmaceuticals do?
Sermonix Pharmaceuticals is a pharmaceuticals company.
Where is Sermonix Pharmaceuticals headquartered?
Sermonix Pharmaceuticals is headquartered in Columbus, US.
Which VCs invest in companies like Sermonix Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Sermonix Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Sermonix Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.